Suzana Couto

Suzana Couto's work experience includes serving as a Scientific Advisor at Nucleai since May 2023. Prior to that, they held the position of Senior Vice President, Pathology and Toxicology at Neomorph, Inc. from April 2023. Suzana has also served as a Board Member at U-VOL FOUNDATION since October 2022 and as a Member at Chief since August 2022. In addition, they were involved in the Pathology Task Force at the American Association for Cancer Research from April 2022. Before that, they were part of the High Content Imaging Working Group at the Foundation for the National Institutes of Health since August 2020. Prior to that, they served at Genmab, where they held several roles including Vice President, Head of Pathology, and Board of Directors alternate member from March 2022 to April 2023, and Head of Pathology from August 2019 to April 2023. Suzana also mentored at the Healthcare Businesswomen's Association - Entrepreneurship from January 2022 to April 2023. Before Genmab, they worked as a Senior Director, Pathology at Celgene from November 2018 to July 2019 and as a Director, Pathology from August 2013 to July 2018.

Suzana Couto's education history is as follows:

From 1992 to 1996, Suzana Couto attended USP - Universidade de São Paulo, where they obtained their Doctor of Veterinary Medicine (DVM) degree. The field of study for this degree is not provided.

From 2001 to 2008, Suzana Couto pursued their higher education at the University of California, Davis. Suzana completed their Doctor of Philosophy (Ph.D.) program in Comparative Pathology during this time.

In 2021, Suzana Couto enrolled in Harvard Business School, where they are currently pursuing a degree in Entrepreneurship essentials. The end year for this education has not been provided.

Additionally, Suzana Couto obtained a certification named "World Business Forum NYC 2022" from WOBI in November 2022.